Form 4: Integra LifeSciences Director Lo Renee Wonlai Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Lo Renee Wonlai reports acquisition and disposal of Integra LifeSciences Holdings Corp (IART) common stock on May 9, 2024.
Summary
- On May 9, 2024, Lo Renee Wonlai, a director of Integra LifeSciences Holdings Corp (IART), reported changes in beneficial ownership of the company's common stock.
- Wonlai acquired 8,696 shares of common stock.
- Wonlai also disposed of 0 shares.
- Following these transactions, Wonlai beneficially owns 16,151 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It simply reports transactions by an insider and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure related to changes in beneficial ownership by a company insider, as required by the SEC. It provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of transaction involving Integra LifeSciences common stock. |
| 05/13/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.